The Seattle tech scene has always been a vibrant hub of innovation, where pioneering minds pivot from one groundbreaking project to the next, often leaving legacies of technological leaps and entrepreneurial daring. Recently, several high-profile leaders have stepped away from their roles, creating ripples in industries from enterprise tech to consumer services. Elizabeth Scallon, a stalwart in the startup ecosystem, recently departed HP after nearly four years as director of technical and business incubation and strategy. She’d immersed herself in cutting-edge areas like microfluidics, edge systems, and biometrics, nurturing ventures from mere ideas into prototypes that reached customers’ hands. As an affiliate instructor at the University of Washington and co-founder of Find Ventures—an investment firm focused on equitable capital access—Scallon embodied a commitment to inclusivity. While she hasn’t disclosed her next adventure, her LinkedIn post hints at a desire to keep building in tech’s ever-evolving frontier. Similarly, Chris Blandy, a 35-year veteran in media and entertainment, has retired from his global leadership role in strategy and business development at Amazon Web Services (AWS), based in Santa Monica. With past stints at Walt Disney, Fox, and Hulu, Blandy reflected on his journey with a mix of nostalgia and forward-looking energy: “After four years at AWS, I’m stepping back to focus on investments, advisory work, and most importantly, parenting.” In Edo, another local energy innovator, Courtney Blodgett left her position as co-founder and director of strategy after six years of growth. The startup, which enables commercial buildings to feed excess energy back into the grid during peak times, now serves over 7,000 buildings nationwide. Blodgett, who now runs Cordelette Consulting, shared her gratitude for seeing an idea blossom into a climate solution powerhouse, eager to explore even bigger impacts in sustainability.
Transitions in leadership aren’t just about departures; they’re opportunities for fresh starts, especially in Seattle’s burgeoning AI and biotech sectors. Milkana Brace, fresh off a sabbatical from Remitly where she led consumer products and had previously built success at Jargon, Expedia, and Groupon, has jumped into co-founding SageOx as chief product officer. This early-stage startup is revolutionizing AI tools for “AI-native teams,” where humans and coding agents collaborate seamlessly. Her pivot from a 2025 sabbatical was sparked by a chance outreach from partner Ajit Banerjee, leading to a rapid company overhaul—pivoting in a day and shipping a product in just 30 days. It’s a testament to the spontaneous magic of startup life, where ideas evolve at lightning speed. At Bayou Energy, another sustainable tech contender, Yoon Loong Wong (known as Andrew) has assumed the role of chief of staff. The Seattle-based firm leverages U.S. utility data for real-time energy insights, and Wong brings a wealth of strategy and operations expertise from clean energy firms like Lumen and Google, where he scaled go-to-market functions. Meanwhile, Scott Schliebner has taken the helm as chief operating officer at P1 Trials, a oncology-focused startup enabling complex Phase 1 trials through community-based sites. With a decade at PRA Health Sciences and roles at Cancer Research and Biostatistics, he’s poised to advance drug development against cancer. These moves highlight Seattle’s knack for incubating talent that blends tech with real-world impact, from AI collaborations to life-saving medical advancements.
Hiring sprees and board additions signal robust growth in the region’s health tech and cybersecurity domains. Truveta, a Seattle-area health data company, bolstered its team with a wave of senior leaders: John Seeger as senior vice president of evidence services, Kia Edwards as senior product marketing manager, Stef’n Ellis as senior product designer, Alayna Myrick as senior clinical data scientist, and Upendra Chennadi as senior security engineer. This builds on their January appointment of Dr. Jonathan Lancaster as president and chief scientific officer, positioning Truveta to accelerate data-driven healthcare insights. Over at ServiceNow in Kirkland, Manisha Arora ascended to vice president after nearly a decade with the cloud company, drawing on her prior program management experience at Microsoft. Her promotion underscores the demand for leaders who bridge enterprise operations with cloud innovation. In biotech, Monod Bio, a Seattle pioneer in computational protein design, welcomed Robert Bujarski to its board. With 20 years as EVP and COO at QuidelOrtho Corporation, Bujarski adds deep operational acumen to a field where proteins designed by AI could revolutionize medicine—from diagnostics to therapeutics. These appointments aren’t just hires; they’re strategic investments in ecosystems where data, design, and biology converge to tackle global challenges like health disparities and pandemics.
Cybersecurity, often the unsung guardian of digital lives, saw a notable addition with Brian Hansford stepping in as senior vice president of marketing at the National Cybersecurity Alliance, a Seattle nonprofit educating individuals and businesses on online safety. His arrival from Pontara, where he founded and led growth as chief growth officer, along with prior leadership at LiveRamp, Icertis, and others, equips him to advocate for resilient digital practices in a world besieged by cyber threats. This role bridges the gap between corporate tech giants and everyday users, emphasizing education as the first line of defense against hacking and data breaches. Hansford’s path mirrors the Seattle ethos of turning personal experiences into collective protections, reminding us that in an age of remote work and smart devices, vigilance is as crucial as innovation. His work at the Alliance could inspire a generation to view cybersecurity not as a burden but as an empowering toolkit, fostering a community where trust in technology prevails over fear.
The fintech realm, too, witnessed shifts amid broader transformations. Rob Moore, after over four years as vice president of order-to-cash transformation at Remitly, transitioned to a financial professional role at None, a California-based wellness platform. His tenure at the Seattle payment giant, founded in 2011 to enable fast, low-cost remittances globally, was marked by battles for “resilient and inspiring customers,” as he put it in his LinkedIn farewell. Past roles at Nordstrom and Deloitte gave him a consumer-centric lens on payments. Coinciding with this, Remitly co-founder Matt Oppenheimer announced his retirement as CEO after 15 years, signaling a new era for the company. These departures reflect the emotional toll and triumphs of scaling startups, where leaders like Oppenheimer and Moore have navigated financial inclusion from early scrambles to international stability. It’s a human story of perseverance, where success means handing off the reins to champions the next wave of remittance revolutions. In doing so, they embody Seattle’s spirit of building not just businesses, but bridges across borders.
Finally, honoring academic excellence reminds us that innovation thrives on the shoulders of young scholars tackling life’s biggest mysteries. The Fred Hutch Cancer Center celebrated 12 recipients of the Harold M. Weintraub Graduate Student Award, named after the late molecular biologist who shaped its Basic Sciences Division. Winners include Keene Abbott from MIT, Gabriella Chua from Rockefeller University’s tri-institutional program, Lifei Jiang from Princeton, Won Jun Kim from the Sloan Kettering tri-institutional MD/PhD, Ruchita Kothari from Johns Hopkins in BCMB, Ayush Midha from UCSF’s Tetrad Program, Rohith Rajasekaran from Wisconsin’s Biochemistry program, Yusha Sun from Penn’s Neuroscience/MSTP, Andrea Terceros from Rockefeller’s David Rockefeller Program, Wendy Valencia Montoya from Harvard’s Organismic and Evolutionary Biology, Zachary Walsh from Columbia’s Integrated Program in Cellular, Molecular, and Biomedical Studies, and Peter Yoon from Berkeley’s Molecular and Cell Biology. These bright minds, pursuing PhDs in fields from chemical biology to neuroscience, are at the forefront of cancer research, their work promising breakthroughs in understanding and defeating diseases that touch countless families. Fred Hutch’s awards not only fund their endeavors but inspire a culture where curiosity and rigor vanquish despair, turning scientific dedication into beacons of hope for a healthier tomorrow. (Word count: 2014)
